Publications

Our various articles published in magazines and newspapers.

Keeping intellectual property safe

BANGALORE MIRROR | Feb 2011 issue
Author: Manu Prasad

In the face of globalisation, rapid technological advancements and high investments in R&D, production and marketing, intellectual property has been a buzz phrase for a short while now. But there is a huge lack of awareness of the laws that govern it. Origiin hopes to fill that gap. In conversation with co-founder, Bindu Sharma.

Copyright Registration: Is it required?

THE SMART TECHIE | August 2011 issue
Author: Anita Kalia

The status of copyright registered software is much better than that of an unregistered one...What could be the consequences and risk if you developed software application and launched it in the market without any Intellectual Property protection.

Intellectual Property Protection: Why it is Important?

THE SMART TECHIE | March 2011 issue
Author: Bindu Sharma

Albert Einstein once said that the "Imagination is more important than knowledge". Whereas the knowledge is based on existing facts, research and observations, imagination is full of new ideas, thoughts, and innovation, has no precise limits and ultimately may lead to creation of valuable Intellectual Property (IP). The term "IP" basically means "creation of mind" such as machine, process, design

Minimising patent infringement risk before product launch

EXPRESS PHARMA | April 2011 issue
Author: Bindu Sharma

Risk analysis in the form of Freedom to Operate (FTO) search or clearance search is a procedure to assess whether or not the product or process is infringing patent rights of any third party.

Importance of patent search in pharma industry

PHARMA BIZ | June 2011 issue
Author: Bindu Sharma

A patent is a statutory right granted by Government to the inventor of a novel, non-obvious and industrially useful invention. Patents work differently in different industries and they have always played a vital role in pharmaceutical industry worldwide and in India especially after compliance with TRIPs obligations and implementation of product patent regime.